Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of ...

Under the influence of “holotropic breathwork,” your brain may be making its own psychedelic compound.

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

Q4 2024 Earnings Call Transcript January 28, 2025 Operator: Good afternoon, and welcome to the Alexandria Real Estate ...

We’re warned that sleeplessness takes a serious toll. But obsessing over how to cure it may be even more damaging.

You do it for us.” Shafter added that while he lives in CdN, he told Mayor Mitchell Brownstein and the council that “you are ...

Discover how to navigate inflation with long-term investments in resilient companies like Coca-Cola, AbbVie, and TC Energy. Read more about our stock picks on Seeking Alpha.

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

The once-promising drug was a potential blockbuster for treating schizophrenia, and was the primary motive for the $8.7 billion Cerevel Therapeutics deal. Analysts have revised their long-term ...

Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...